Precision Nanosystems
2022 in review: Regulation starts to catch up with AI in pharma
As AI takes over drug discovery and clinical research, governments prioritise the regulation of AI in pharma.
Can your LNP manufacturing platform cope with the pace of the mRNA revolution?
Using analytics and bioassays to de-risk your mRNA LNP drug development programme
